How one CDMO used innovative technology to overcome viral vaccine production challenges?
Discover how Ology Biosciences is leveraging Univercells Technologies’ intensified fixed-bed bioreactor and bioprocessing expertise to bring vaccine production to the next level. Get case study results and expert insights on how to find success with adherent-cell growth profiles and viral performance to produce viral vaccines using the scale-X bioreactors.
Visit site